FAQ/Help |
Calendar |
Search |
Today's Posts |
![]() |
#1 | |||
|
||||
Senior Member
|
Yet another drug for RRMS--brand name Kesimpta (ofatumumab)--has received FDA approval according to this article in MarketWatch (August 21, 2020):
Novartis MS drug Kesimpta gets FDA approval - MarketWatch
__________________
Repeal the law of gravity! MS diagnosed 1980. Type 2 diabetes, osteoarthritis, osteopenia. Avonex 2002-2005. Copaxone 6/4/07-5/15/10. Currently: Glatopa (generic Copaxone), 40mg 3 times/week, 12/16/20 - 3/16/24 |
|||
![]() |
![]() |
Reply |
Thread Tools | |
Display Modes | |
|
|
![]() |
||||
Thread | Forum | |||
New here with TM & RRMS | Multiple Sclerosis | |||
RRMS to SPMS | Multiple Sclerosis | |||
RRMS vs ... Does it really have to be? (vent) | Multiple Sclerosis | |||
RRMS to SPMS how did you get there? | Multiple Sclerosis | |||
When does RRMS become SPMS? | Multiple Sclerosis |